Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Edoxaban PK/PD in Pediatric Patients
NCT02303431Phase 1Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Nov 2014
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 9
01
Overview
Phase 1, open-label trial of edoxaban in deep vein thrombosis (DVT) and venous thromboembolism (VTE) (10 cohorts), sponsored by Daiichi Sankyo Co., Ltd. Primary endpoints: Apparent Systemic Clearance and Apparent Volume of Distribution. Started Nov 2014; status: completed.
02
Drugs
edoxaban
03
Conditions
deep vein thrombosis (DVT)venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT02303431.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02303431.